Salicylate inhibits macrophage-secreted factors induced adipocyte inflammation and changes of adipokines in 3T3-L1 adipocytes

Inflammation

Volumn 32, Issue 5, 2009, Pages 296-303

  An, Yuan ^a   Liu, Kang ^a   Zhou, Yuan ^a   Liu, Baolin ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Adipocytes; Adipokines; Insulin resistance; Macrophage; Salicylates

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESISTIN; SALICYLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; GLUCOSE INTAKE; INCUBATION TIME; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; UPREGULATION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOKINES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; INFLAMMATION; MACROPHAGES; MICE; SALICYLATES; TIME FACTORS;

EID: 70349696287     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-009-9135-1     Document Type: Article

References (27)

1. H. Xu G. T. Barnes Q. Yang G. Tan D. Yang C. J. Chou J. Sole A. Nichols J. S. Ross L. A. Tartag H. Chen 2003 Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J. Clin. Invest 112 1821 1830 14679177 1:CAS:528:DC%2BD3sXhtVSmtLvI
2. G. S. Hotamisligil 2006 Inflammation and metabolic disorders Nature 444-14 860 867 10.1038/nature05485 (Pubitemid 46024993)
3. P. Dandona A. Aljada A. Bandhopadhyay 2004 Inflammation: the link between insulin resistance, obesity and diabetes Trends Immunol 25 4 7 14698276 10.1016/j.it.2003.10.013 1:CAS:528:DC%2BD3sXhtVSjtL7N (Pubitemid 38032801)
4. A. Festa, et al. 2000 Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS) Circulation 102 42 47 10880413 1:STN:280:DC%2BD3czkt1ymtQ%3D%3D
5. J. L. Steven E. Shoelson A. B. Goldfine 2006 Inflammation and insulin resistance J. Clin. Invest 116 1793 1801 10.1172/JCI29069
6. R. Cancello C. Henegar N. Viguerie S. Taleb C. Poitou C. Rouault M. Coupaye V. Pelloux D. Hugol J. L. Bouillot A. Bouloumie G. Barbatelli S. Cinti P. A. Svensson G. S. Barsh J. Zucker A. Basdevant D. Langin K. Clement 2005 Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery induced weight loss Diabetes 54 2277 2286 16046292 10.2337/diabetes.54.8.2277 1:CAS:528:DC%2BD2MXnt1ynsbo%3D (Pubitemid 41134253)
7. K. Clement N. Viguerie C. Poitou C. Carette V. Pelloux C. A. Curat A. Sicard S. Rome A. Benis J. D. Zucker H. Vidal M. Laville G. S. Barsh A. Basdevant V. Stich R. Cancello D. Langin 2004 Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects FASEB J 18 1657 1669 15522911 10.1096/fj.04-2204com 1:CAS:528:DC%2BD2cXpslGku7s%3D (Pubitemid 39463705)
8. A. Bizzi A. M. Codegoni S. Garattini 1964 Salicylate, a powerful inhibitor of free fatty acid release Nature 204 1205 14264385 10.1038/2041205a0 1:CAS:528:DyaF2MXjvFGltA%3D%3D
9. L. Zu, et al. 2008 Salicylate blocks lipolytic actions of tumor necrosis factor-α in primary rat adipocytes Molecular Pharmacology Fast Forward 73 215 223 1:CAS:528:DC%2BD1cXkslGjug%3D%3D
10. P. S. Schonhofer J. Sohn H. D. Peters V. Dinnendahl 1973 Effects of sodium salicylate and acetylsalicylic acid on the lipolytic system of fat cells Biochem. Pharmacol 22 5 629 637 4348116 10.1016/0006-2952(73)90377-8 1:STN:280:DyaE3s7kt1Wkuw%3D%3D
11. S. E. Shoelson J. Lee M. Yuan 2003 Inflammation and the IKKb/IjB/NF-jB axis in obesity- and diet-induced insulin resistance Int. J. Obes 27 49 52 10.1038/sj.ijo.0802501 (Pubitemid 38019189)
12. R. F. Grimble 2002 Inflammatory status and insulin resistance Curr. Opin. Clin. Nutr. Metab. Care 5 551 559 12172480 10.1097/00075197-200209000-00015 1:CAS:528:DC%2BD38Xmslartro%3D (Pubitemid 40684652)
13. K. E. Wellen G. S. Hotamisligil 2005 Inflammation, stress, and diabetes J. Clin. Invest. 115 1111 1119 15864338 1:CAS:528:DC%2BD2MXktFSksbY%3D
14. J. M. Harkins N. Moustaid-Moussa Y.-J. Chung 2004 Expression of interleukin-6 is greater in preadipocytes than in adipocytes of 3T3-L1 cells and C57BL/6J and ob/ob mice J. Nutrition 134 2673 2677 1:CAS:528: DC%2BD2cXosV2jtbg%3D
15. M. Fasshauer S. Kralisch L. M. U. Klier M. Bluher J. Klein R. Paschke 2003 Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes Biochem. Biophys. Res. Commun 301 1045 1050 12589818 10.1016/S0006-291X(03)00090-1 1:CAS:528:DC%2BD3sXhtVerurs%3D (Pubitemid 36279218)
16. F. Ma 2007 gp130 receptor ligands as potential therapeutic targets for obesity J. Clin. Invest. 117 841 849 10.1172/JCI30453 (Pubitemid 46556736)
17. H. Tilg A. R. Moschen 2008 Inflammatory mechanisms in the regulation of insulin resistance Mol. Med. 14 3-4 222 231 18235842 1:CAS:528: DC%2BD1cXksVensrk%3D
18. C.-P. Liang S. Han T. Senokuchi A. R. Tall 2007 The macrophage at the crossroads of insulin resistance and atherosclerosis Circ. Res. 100 1546 1555 17556668 10.1161/CIRCRESAHA.107.152165 1:CAS:528:DC%2BD2sXmtVGjtLc%3D (Pubitemid 46897258)
19. H. Shi M. V. Kokoeva K. Inouye I. Tzameli H. Yin J. S. Flier 2006 TLR4 links innate immunity and fatty acid-induced insulin resistance J. Clin. Invest. 116 3015 3025 17053832 10.1172/JCI28898 1:CAS:528:DC%2BD28XhtFyrsLfE (Pubitemid 44684486)
20. G. S. Hotamisligil P. Arner J. F. Caro R. L. Atkinson B. M. Spiegelman 1995 Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance J. Clin. Invest. 95 5 2409 2415 7738205 10.1172/JCI117936 1:CAS:528:DyaK2MXltlWru70%3D
21. K. M. Ajuwon M. E. Spurlock 2005 Adiponectin inhibits LPS-induced NF-kappa B activation and IL-6 production and increases PPAR-gamma expression in adipocytes Am. J. Physiol. Regul. Integr. Comp. Physiol 288 R1220 R1225 15604306 1:CAS:528:DC%2BD2MXktlSgs7g%3D
22. J. Ye 2008 Regulation of PPAR-gamma function by TNF-a Biochem. Biophys. Res. Commun. 374 405 408 18655773 10.1016/j.bbrc.2008.07.068 1:CAS:528:DC%2BD1cXhtVSiur3O
23. C. M. Kusminski P. G. McTernan S. Kumar 2005 Role of resistin in obesity, insulin resistance and Type II diabetes Clin. Sci. (Lond.) 109 243 256 1:CAS:528:DC%2BD2MXoslKgu7w%3D
24. E. D. Muse T. K. Lam P. E. Scherer L. Rossetti 2007 Hypothalamic resistin induces hepatic insulin resistance J. Clin. Invest. 117 1670 1678 17525801 10.1172/JCI30440 1:CAS:528:DC%2BD2sXmsVWku70%3D (Pubitemid 46871351)
25. E. W. Zur 1876 Therapie des diabetes mellitus, insbesondere über die Anwendung des salicylsauren Natron bei demselben Berliner Klinische Wochenschrift 13 337 340
26. M. J. Yin Y. Yamamoto R. B. Gaynor 1998 The antiinflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta Nature 396 77 80 9817203 10.1038/23948 1:CAS:528:DyaK1cXnsVSjur0%3D (Pubitemid 28520452)
27. K. E. Wellen G. S. Hotamisligil 2003 Obesity-induced inflammatory changes in adipose tissue J. Clin. Invest 112 1785 1788 14679172 1:CAS:528: DC%2BD3sXhtVSmtLrE